
|Articles|October 1, 2002
Cole Eye Institute: Cleveland Clinic adds two specialists
Cleveland-A specialist in neuro-ophthalmology and a specialist in corneal and autoimmune disorders have joined the staff of the Cole Eye Institute at the Cleveland Clinic.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Lotus submits NDA in South Korea for LENZ’s presbyopia treatment VIZZ
2
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%.
3
EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada
4
Collarettes common but largely stable in moderate-to-severe dry eye patients
5

















































.png)


